Results 121 to 130 of about 12,023 (229)

Cabergolin

DMW - Deutsche Medizinische Wochenschrift, 2009
Mönig, H, Krack, Paul
openaire   +3 more sources

Cabergoline as a Preventive Migraine Treatment: An Investigator-Initiated Randomized Controlled Trial [PDF]

, 2023
Astrid Johannesson Hjelholt, Flemming W. Bach, Helge Kasch, Henrik Støvring, Troels S. Jensen, Jens Otto Lunde Jørgensen   +5 more
openalex   +1 more source

The Effect of Cabergoline on the Clinical and Immunological Aspects of Rheumatoid Arthritis Induced in Wistar Rats

Armaghane Danesh Bimonthly Journal, 2019
Background & aim: The anti-inflammatory effects of cabergoline have been documented in various studies. The purpose of the present study was to evaluate the effects of cabergoline administration (as a potent D2 agonist) on clinical aspects and immune ...
E Shaftaloud, SM Abtahi Froushani, N Delirezh   +2 more
doaj  

Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas [PDF]

, 2015
Renata S. Auriemma, Mariano Galdiero, Pasquale Vitale, Luciana Granieri, Fabio Lo Calzo, Ciro Salzano, Lucia Ferreri, Claudia Pivonello, Federica Cariati, Giorgio Coppola, Cristina de Angelis, Annamaria Colao, Rosario Pivonello   +12 more
openalex   +1 more source

Home range, habitat selection and diet of foxes (vulpes vulpes) in a semi-urban riparian environment

, 2006
Between 2000 and 2002 the home range, habitat selection and diet of foxes were examined in the Dandenong Creek Valley, Melbourne, Australia. The mean home range was 44.6 ha (range 19.2–152.6 ha). A significant selection towards blackberry and gorse
Anne Morton, Boulanger, Damuth, Fridell, Harris, Harris, John G. White, Kelly Snell, Nathalie Smallman, Robert Gubiani   +9 more
core   +1 more source

Cabergoline Tapering Is Almost Always Successful in Patients With Macroprolactinomas [PDF]

, 2017
A.C. Paepegaey, Sylvie Salenave, Peter Kamenický, Luigi Maione, Sylvie Brailly‐Tabard, Jacques Young, Philippe Chanson   +6 more
openalex   +1 more source

Efficacy and safety of high-dose long-acting repeatable octreotide as monotherapy or in combination with pegvisomant or cabergoline in patients with acromegaly not adequately controlled by conventional regimens: results of an open-label, multicentre study

, 2019
Annamaria Colao, Wojciech Zgliczyński, Jan Komorowski, Beata Kos‐Kudła, Antoine Tabarin, V. Kerlan, Francesco Minuto, Carla Scaroni, Marek Bolanowski   +8 more
openalex   +2 more sources

Prolactin ≤1 ng/mL predicts macroprolactinoma reduction after cabergoline therapy [PDF]

, 2019
Daham Kim, Cheol Ryong Ku, Kyungwon Kim, Hyein Jung, Eun Jig Lee   +4 more
openalex   +1 more source

Inhibiting prolactin by cabergoline accelerates mammary gland remodeling during the early dry period in dairy cows [PDF]

, 2017
Marion Boutinaud, N. Isaka, Eva Gandemer, Philippe Lamberton, Sandra Wiart, Ana I. de Prado Taranilla, Lorraine M. Sordillo, Vanessa Lollivier   +7 more
openalex   +1 more source

Comparison of coasting with Cabergoline administration for prevention of early severe OHSS in ART cycles [PDF]

, 2008
Abbas Aflatoonian, Sedigheh Ghandi, Nasim Tabibnejad   +2 more
openalex